Alvotech (ALVO) Gross Margin (2022 - 2026)
Alvotech's (ALVO) quarterly Gross Margin came in at 9.95% in Q1 2026, down 3050.0% YoY from 0.34% in Q1 2025, and up 117.28% on a QoQ basis from 57.58% in Q4 2025.
Alvotech (ALVO) Gross Margin (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of Gross Margin data on file, last reported at 9.95% in Q1 2026.
- Quarterly Gross Margin fell 3050.0% year-over-year to 9.95% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.62% (up 6226.0% YoY) and the FY2025 annual result came in at 14.74%, down 1750.0% from the prior year.
- Gross Margin improved to 9.95% in Q1 2026, from 57.58% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 40.45% in Q1 2025 to a low of 751.13% in Q4 2023.
- A 5-year average of 154.43% and a median of 60.88% in 2024 frame the typical range for Gross Margin.
- Annual changes were most pronounced in 2023 — Gross Margin sank 38587 bps — and 2024, when it soared 56999 bps.
- Tracing ALVO's Gross Margin over 5 years: stood at 365.27% in 2022, then slumped by 106 bps to 751.13% in 2023, then surged by 76 bps to 181.15% in 2024, then jumped by 68 bps to 57.58% in 2025, then soared by 117 bps to 9.95% in 2026.
- The last three Gross Margin figures came in at 9.95% (Q1 2026), 57.58% (Q4 2025), and 7.22% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 51.98% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 42.63% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 66.66% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 87.30% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 38.77% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 97.58% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 58.33% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alvotech | 1.22 Bn | 1.22 Bn | 5.09 Mn | 9.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.95% |
| Dec 31, 2025 | -57.58% |
| Sep 30, 2025 | -7.22% |
| Jun 30, 2025 | 22.15% |
| Mar 31, 2025 | 40.45% |
| Dec 31, 2024 | -181.15% |
| Sep 30, 2024 | 35.90% |
| Jun 30, 2024 | -60.88% |
| Mar 31, 2024 | -60.56% |
| Dec 31, 2023 | -751.13% |
| Jun 30, 2023 | -146.36% |
| Mar 31, 2023 | -146.44% |
| Dec 31, 2022 | -365.27% |
| Jun 30, 2022 | -361.64% |
| Mar 31, 2022 | -286.73% |